Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 14 Protection of the injured party

1 Can­cel­la­tion of the in­sur­ance policy by the in­sur­ance com­pany is not per­miss­ible after the oc­cur­rence of the in­sured event.

2 With­in the frame­work of the in­sur­ance cov­er­age, the in­jured party or leg­al suc­cessor has a dir­ect claim against the in­sur­ance com­pany. Ob­jec­tions can­not be raised on the basis of the in­sur­ance policy or the In­sur­ance Policies Act of 2 April 190826.

3 If the in­sur­ance com­pany is sub­ject to ac­tion un­der para­graph 2, it shall have a right of re­course against the in­sured party.

4 Para­graphs 1–3 ap­ply mu­tatis mutandis if se­cur­ity of equi­val­ent value is provided in ac­cord­ance with Art­icle 13 para­graph 1 let­ter b.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden